Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor
Antibody immobilisation is the cornerstone of antibody-based assay in biosensing technology which is predominantly used to detect and measure a wide variety of biological analytes, ranging from antigens, biomarkers, allergens and drug substances. As such, specific interactions between antibody and l...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2017
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/45441/1/NG%20WOEI%20KEAN.pdf |
| _version_ | 1797011378112823296 |
|---|---|
| author | Ng,, Woei Kean |
| author_facet | Ng,, Woei Kean |
| author_sort | Ng,, Woei Kean |
| collection | USM |
| description | Antibody immobilisation is the cornerstone of antibody-based assay in biosensing technology which is predominantly used to detect and measure a wide variety of biological analytes, ranging from antigens, biomarkers, allergens and drug substances. As such, specific interactions between antibody and ligands are therefore needed to guarantee highest reproducibility and sensitivity possible. The complexity of pinning antibodies forms the key factor in interfering the outcome of an assay as the recognition molecule, i.e. the antibody itself, may have undergone structural changes and distortion when it is attached to the solid phase. |
| first_indexed | 2024-03-06T15:33:28Z |
| format | Thesis |
| id | usm.eprints-45441 |
| institution | Universiti Sains Malaysia |
| language | English |
| last_indexed | 2024-03-06T15:33:28Z |
| publishDate | 2017 |
| record_format | dspace |
| spelling | usm.eprints-454412019-09-17T06:44:13Z http://eprints.usm.my/45441/ Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor Ng,, Woei Kean R735-854 Medical education. Medical schools. Research Antibody immobilisation is the cornerstone of antibody-based assay in biosensing technology which is predominantly used to detect and measure a wide variety of biological analytes, ranging from antigens, biomarkers, allergens and drug substances. As such, specific interactions between antibody and ligands are therefore needed to guarantee highest reproducibility and sensitivity possible. The complexity of pinning antibodies forms the key factor in interfering the outcome of an assay as the recognition molecule, i.e. the antibody itself, may have undergone structural changes and distortion when it is attached to the solid phase. 2017-08 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/45441/1/NG%20WOEI%20KEAN.pdf Ng,, Woei Kean (2017) Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor. PhD thesis, Universiti Sains Malaysia. |
| spellingShingle | R735-854 Medical education. Medical schools. Research Ng,, Woei Kean Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor |
| title | Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor |
| title_full | Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor |
| title_fullStr | Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor |
| title_full_unstemmed | Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor |
| title_short | Development Of Antibody Immobilisation Strategy Using Recombinant Human Neonatal Fc Receptor |
| title_sort | development of antibody immobilisation strategy using recombinant human neonatal fc receptor |
| topic | R735-854 Medical education. Medical schools. Research |
| url | http://eprints.usm.my/45441/1/NG%20WOEI%20KEAN.pdf |
| work_keys_str_mv | AT ngwoeikean developmentofantibodyimmobilisationstrategyusingrecombinanthumanneonatalfcreceptor |